Skip to main content
. 2020 Jan 28;21(3):824. doi: 10.3390/ijms21030824
T2DM type 2 diabetes mellitus
BBB blood—brain barrier
FGF21 fibroblast growth factor 21
rFGF21 recombinant fibroblast growth factor 21
FGFR1 fibroblast growth factor receptor 1
PPARγ peroxisome proliferator-activated receptor gamma
dMCAO distal middle cerebral artery occlusion
HBMEC human brain microvascular endothelial cell
IL-1β interleukin-1β
FITC fluorescein isothiocyanate
EMSA electrophoretic mobility shift assay